Archean Chemical Industries Limited (NSE:ACI)
| Market Cap | 66.20B -11.5% |
| Revenue (ttm) | 10.81B +3.8% |
| Net Income | 1.07B -34.1% |
| EPS | 8.65 -34.1% |
| Shares Out | 123.46M |
| PE Ratio | 61.99 |
| Forward PE | 25.20 |
| Dividend | 2.50 (0.47%) |
| Ex-Dividend Date | Jun 5, 2026 |
| Volume | 90,335 |
| Open | 538.00 |
| Previous Close | 536.20 |
| Day's Range | 525.40 - 541.45 |
| 52-Week Range | 483.00 - 727.60 |
| Beta | 0.32 |
| Analysts | Hold |
| Price Target | 580.67 (+8.44%) |
| Earnings Date | May 11, 2026 |
About NSE:ACI
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for use as a water-soluble fertiliser in agricultural applications. Archean Chemical Industries Limited was founded in 200... [Read more]
Financial Performance
In fiscal year 2026, NSE:ACI's revenue was 10.81 billion, an increase of 3.85% compared to the previous year's 10.41 billion. Earnings were 1.07 billion, a decrease of -34.10%.
Financial StatementsNews
Archean Chemical Industries Transcript: Q4 25/26
Q4 FY 2026 saw lower revenue and EBITDA due to logistics and pricing pressures in industrial salt, while bromine and derivatives showed strong volume and price growth. Strategic initiatives include brine field expansion and a new semiconductor project, with margin recovery expected as costs normalize.
Archean Chemical Industries Quarterly report: Q4 2026
Archean Chemical Industries has published its Q4 2026 quarterly earnings report on May 13, 2026.
Archean Chemical Industries Slides: Q4 2026
Archean Chemical Industries has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 13, 2026.
Archean Chemical Industries Annual report: Q4 2026
Archean Chemical Industries has published its Q4 2026 annual report on May 13, 2026.
Archean Chemical Industries Transcript: Q3 25/26
Q3 saw modest revenue growth and margin pressure due to higher costs and operational challenges, but demand for bromine and industrial salt remains robust. Strategic projects in semiconductors and energy storage are progressing, with SOP and derivatives businesses expected to ramp up in FY27.
Archean Chemical Industries Quarterly report: Q3 2026
Archean Chemical Industries has published its Q3 2026 quarterly earnings report on February 6, 2026.
Archean Chemical Industries Slides: Q3 2026
Archean Chemical Industries has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 6, 2026.
Archean Chemical Industries Transcript: Q2 25/26
Revenue grew 10% year-over-year in H1 FY 2026 despite monsoon and macro headwinds, with strong demand for bromine and industrial salt. Major milestones include India Semiconductor Mission approval and progress in energy storage and SOP. Net profit rose 28% year-over-year.
Archean Chemical Industries Quarterly report: Q2 2026
Archean Chemical Industries has published its Q2 2026 quarterly earnings report on November 18, 2025.
Archean Chemical Industries Slides: Q2 2026
Archean Chemical Industries has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 18, 2025.
Archean Chemical Industries Transcript: Q1 25/26
Q1 FY26 delivered 30% YOY revenue growth, with strong performance in bromine and industrial salt, and robust margins. Strategic projects in SOP, bromine derivatives, and energy storage are progressing, while guidance for core segments remains intact.
Archean Chemical Industries Quarterly report: Q1 2026
Archean Chemical Industries has published its Q1 2026 quarterly earnings report on July 31, 2025.
Archean Chemical Industries Slides: Q1 2026
Archean Chemical Industries has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 31, 2025.